ATE105563T1 - Retinsaeureester von l-cladinos, verfahren zu deren herstellung und ihre verwendung in der human- oder veterinaermedizin und in der kosmetik. - Google Patents

Retinsaeureester von l-cladinos, verfahren zu deren herstellung und ihre verwendung in der human- oder veterinaermedizin und in der kosmetik.

Info

Publication number
ATE105563T1
ATE105563T1 AT9090400723T AT90400723T ATE105563T1 AT E105563 T1 ATE105563 T1 AT E105563T1 AT 9090400723 T AT9090400723 T AT 9090400723T AT 90400723 T AT90400723 T AT 90400723T AT E105563 T1 ATE105563 T1 AT E105563T1
Authority
AT
Austria
Prior art keywords
human
cladinos
retin
cosmetics
processes
Prior art date
Application number
AT9090400723T
Other languages
English (en)
Inventor
Michel Philippe
Henri Sebag
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE105563T1 publication Critical patent/ATE105563T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
AT9090400723T 1989-03-16 1990-03-16 Retinsaeureester von l-cladinos, verfahren zu deren herstellung und ihre verwendung in der human- oder veterinaermedizin und in der kosmetik. ATE105563T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8903461A FR2644459B1 (fr) 1989-03-16 1989-03-16 Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
EP90400723A EP0388314B1 (de) 1989-03-16 1990-03-16 Retinsäureester von l-Cladinos, Verfahren zu deren Herstellung und ihre Verwendung in der Human- oder Veterinärmedizin und in der Kosmetik

Publications (1)

Publication Number Publication Date
ATE105563T1 true ATE105563T1 (de) 1994-05-15

Family

ID=9379762

Family Applications (1)

Application Number Title Priority Date Filing Date
AT9090400723T ATE105563T1 (de) 1989-03-16 1990-03-16 Retinsaeureester von l-cladinos, verfahren zu deren herstellung und ihre verwendung in der human- oder veterinaermedizin und in der kosmetik.

Country Status (8)

Country Link
US (1) US5096713A (de)
EP (1) EP0388314B1 (de)
JP (1) JPH02268193A (de)
AT (1) ATE105563T1 (de)
CA (1) CA2012218A1 (de)
DE (1) DE69008762T2 (de)
ES (1) ES2052201T3 (de)
FR (1) FR2644459B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
FR2735694B1 (fr) * 1995-06-20 1997-08-08 Roussel Uclaf Le cladinose a titre de medicament et les compositions pharmaceutiques les renfermant
WO2004010966A1 (ja) * 2002-07-25 2004-02-05 Lion Corporation 外用剤組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984544A (en) * 1975-02-28 1976-10-05 Schering Corporation Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor
US4108880A (en) * 1975-11-03 1978-08-22 Johnson & Johnson Esters of retinoic acid
US4216224A (en) * 1978-09-22 1980-08-05 Scott Eugene J Van Methods and compositions for treating psoriasis with retinoyl compounds
CH661516A5 (de) * 1983-12-08 1987-07-31 Hoffmann La Roche Phenylnonatetraenoylzuckerderivate.
AU599135B2 (en) * 1986-07-16 1990-07-12 Albert M. Kligman Methods for treatment of sundamaged human skin with retinoids
US4885311A (en) * 1987-06-29 1989-12-05 Molecular Design International Topical transretinoids for treatment of acne and skin diseases

Also Published As

Publication number Publication date
FR2644459A1 (fr) 1990-09-21
DE69008762T2 (de) 1994-08-25
DE69008762D1 (de) 1994-06-16
CA2012218A1 (fr) 1990-09-16
EP0388314B1 (de) 1994-05-11
EP0388314A1 (de) 1990-09-19
JPH02268193A (ja) 1990-11-01
US5096713A (en) 1992-03-17
FR2644459B1 (fr) 1994-10-28
ES2052201T3 (es) 1994-07-01

Similar Documents

Publication Publication Date Title
DE69215595D1 (de) Isochinolin-5-yl-Sulfonsäureamide, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
SE8700498D0 (sv) Novel pharmaceologically active compounds
IL87488A0 (en) Pharmaceutical compositions for the topical treatment of conditions associated with photodamaged skin,comprising substituted propenyl phenyl derivatives
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE3854854D1 (de) 3-Desmethyl-mevalonsäurederivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen, ihre Verwendung sowie Zwischenprodukte
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
SE8403487D0 (sv) Farmaceutisk komposition
DE59005254D1 (de) 24-Homo-Vitamin-D-Derivate, Verfahren zu ihrer Herstellung; diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung als Arzneimittel.
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DE59006893D1 (de) Pyrimidin-4,6-dicarbonsäurediamide, Verfahren zu deren Herstellung sowie Verwendung derselben sowie Arzneimittel auf Basis dieser Verbindungen.
ATE161419T1 (de) Kosmetische zusammensetzung, die einen lipidstoff und eine hydroxy - oder ketofettsäure enthält
SE8701406L (sv) Aromatiska foreningar, deras framtellningsforfarande och deras anvendning inom human- och veterinermedicinen och inom kosmetiken
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
ES2129112T3 (es) Compuestos aromaticos policiclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ATE105563T1 (de) Retinsaeureester von l-cladinos, verfahren zu deren herstellung und ihre verwendung in der human- oder veterinaermedizin und in der kosmetik.
IT8368279A0 (it) 5 idrossinaftochinoni per la tintura delle fibre cheratiniche umane procedimento di tintura utilizzante tali composti e composizione tintoria contenente i composti stessi
DE3586194D1 (de) Bioemulgatoren enthaltende kosmetische und pharmazeutische zusammensetzungen.
NO891220D0 (no) Middel som inneholder salicylsyre for behandling av lepidose.
ATE3634T1 (de) Adamantylalkyloxycarbonylderivate, deren herstellung und verwendung zur darstellung von peptiden.
ATE105564T1 (de) Retinsaeureester von d-desosamin, verfahren zu deren herstellung und ihre verwendung in der human- oder veterinaermedizin und in der kosmetik.
DE3575139D1 (de) Phenylnaphthyridine, verfahren zu deren herstellung, diese enthaltende arzneimittel, insbesondere antigeschwuer.
ATE90095T1 (de) Optisch aktive produkte von 20,21dinoreburnamenin-derivaten,verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
DE69316324D1 (de) 4-Hydroxy-phenyl-beta-D-glukose-monoester, Verfahren zur ihrer Herstellung und ihre Verwendung in der Kosmetik, der Pharmazie, als Zahnpflegemitteln und Lebensmitteln
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
ATE59035T1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties